(Q25255831)

English

A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

1 reference

based on heuristic

inferred from title

A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

0 references

Adaptive radiation therapy

0 references

0 references

head and neck squamous cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Budach W

1

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Hehr T

2

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Budach V

3

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Belka C

4

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Dietz K

5

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

language of work or name

0 references

publication date

31 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

1

0 references

28

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379652

28 September 2017

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379652

28 September 2017

Hyperfractionated radiotherapy in head and neck cancer: a second look at the clinical data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379652

28 September 2017

A review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379652

28 September 2017

Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379652

28 September 2017

Hyperfractionation: where do we stand?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379652

28 September 2017

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379652

31 May 2018

Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379652

31 May 2018

Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: experience of the European Organization for Research and Treatment of Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379652

31 May 2018

Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379652

31 May 2018

Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379652

31 May 2018

A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379652

31 May 2018

Simultaneous Chemoradiation in the Treatment of Advanced Head and Neck Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379652

31 May 2018

Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-28

21 January 2018

A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-28

21 January 2018

Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiothera

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-28

21 January 2018

Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-28

21 January 2018

Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-28

21 January 2018

Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-28

21 January 2018

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-28

21 January 2018

Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-28

21 January 2018

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-28

21 January 2018

The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-28

21 January 2018

Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck: results from a phase III randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379652

28 November 2018

A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-28

21 January 2018

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of stages III and IV head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local control, TCD50 and dose-time prescription habits in radiotherapy of head and neck tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation dose-response of human tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of hyperfractionated radiation therapy in randomized clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant radiotherapy with mitomycin C and bleomycin compared with radiotherapy alone in inoperable head and neck cancer: final report

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16448551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-28

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1186/1471-2407-6-28

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Dimensions Publication ID

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q25255831&oldid=2177057372"